A tool for visualizing genomic data to improve cancer treatment
The Integrative Genomics Viewer (IGV) for Cancer Research
This study is working on improving a tool called the Integrative Genomics Viewer (IGV), which helps doctors and researchers look at complex genetic information about cancer, so they can better understand it and find new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10901975 on NIH RePORTER |
What this research studies
This research focuses on enhancing the Integrative Genomics Viewer (IGV), a software tool that allows researchers and clinicians to visualize complex genomic data related to cancer. By collaborating with end users, the project aims to evolve IGV to incorporate the latest advancements in genomics technology, ensuring it remains a valuable resource for interpreting genetic variations. The enhancements will include new visualizations and features that facilitate the analysis of both short and long read genomic data, ultimately aiding in the development of novel cancer treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer who may benefit from personalized treatment strategies informed by genomic data.
Not a fit: Patients with non-cancerous conditions or those not undergoing genomic analysis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for various cancers through better genomic data interpretation.
How similar studies have performed: Previous research has successfully utilized similar genomic visualization tools, indicating a strong potential for this approach to yield beneficial outcomes.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Mesirov, Jill P. — University of California, San Diego
- Study coordinator: Mesirov, Jill P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.